×

PMDA

shutterstock_552100717

Japan renews its participation in MDSAP until 2020

By Luis Jimenez | 05.02.2019
Japan’s participation in MDSAP (Medical Device Standardized Audit Program) has been a contributing factor in the exponential update of MDSAP by multinational companies. Japan’s MHLW and PMDA has been opting...
Brandwood Biomedical global experts medical devices regulatory affairs consulting medical devices IVDs Brandwood Biomedical Global Expertise in Medical Device Regulatory Compliance Australia China Taiwan Hong Kong Europe New Zealand United States

Australia via 510(k): TGA – recognises US, Canadian and Japanese approvals with MDSAP

By Arthur Brandwood | 08.30.2018
Australia’s regulatory system is modelled very closely on that of Europe. This equivalence of requirements and assessment pathways has allowed TGA to leverage prior CE marking to grant Australian device...

Search

Recent Posts

TGA Regulatory Business Plan 2019-2020

Oct 1, 2019

Breast implants and anaplastic large cell lymphoma

Oct 1, 2019

Update on Implant Card Requirements

Sep 25, 2019

Custom Devices, Clinical Trials and the Hazards of Precedent

Sep 2, 2019

Make your transition from MDD to MDR – White Paper

Aug 30, 2019

EVIDENCE MATTERS: for new and established medicines

Aug 26, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) adverse events Apple Watch Artificial Intelligence Australia Biocompatibility Biomechanics Brexit CE CE Certificates CFDA China distribution Europe FDA Health Canada IVD IVDR MDD MDR MDSAP mechanical properties medical device medical devices New Zealand Notified Bodies PMA PMDA post market postmarket private health insurance QMS Quality Systems Reform regulatory Reimbursement SaMD Software standards Sterilisation TGA UDI Webinar
Translate »